All news

Journey Medical misses estimates as revenue falls short

Alpha Vantage · Investing.com · · AI-summarised by FinFlash

Journey Medical (NASDAQ: DERM) posted third-quarter EPS of $-0.050, missing analyst estimates by $0.07, while revenue of

Read original source

DERM company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.